Skip to content

The Effect of Nocturnal Haemodialysis on Arterial Stiffness

The Effect of Nocturnal Haemodialysis on Arterial Stiffness

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00641875
Enrollment
30
Registered
2008-03-24
Start date
2005-12-31
Completion date
2008-02-29
Last updated
2015-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Stiffness, End Stage Renal Disease

Keywords

arterial stiffness, artery, aortic pulse wave velocity, pulse wave analysis, augmentation index, end stage renal disease, nocturnal hemodialysis, extended hours of hemodialysis, cardiovascular, hemodialysis

Brief summary

Arterial stiffness refers to the accumulation of extracellular deposits of matrix and calcium which reduce blood vessel compliance. Although there is growing evidence that increased arterial stiffness is associated with chronic kidney disease (CKD), its pathogenesis is unclear. Pulse wave velocity (PWV) and augmentation index (AIx) provide tools for estimating arterial stiffness, and therefore predicting cardiovascular morbidity and mortality. The aims of the study are: (1) compare the effects of nocturnal and conventional haemodialysis on arterial stiffness, and (2) examine the relationship between arterial stiffness and clinical and biochemical parameters.

Interventions

PROCEDURENocturnal Hemodialysis

Sponsors

Melbourne Health
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* adult dialysis patients * able to perform home nocturnal haemodialysis

Exclusion criteria

* age \< 18 and \> 80 years * any patient who is anticipating a live renal transplantation in forthcoming 12 months

Design outcomes

Primary

MeasureTime frame
To purpose of this study is to evaluate the arterial stiffness in subjects who have undergone 12 months nocturnal haemodialysis.12 months

Secondary

MeasureTime frame
To examine the relationship between arterial stiffness and clinical and biochemical parameters12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026